{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:28:08Z","timestamp":1793932088190,"version":"4.8.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"U.S. Defense Health Agency Research and Development Program","award":["D1430"],"award-info":[{"award-number":["D1430"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Malaria rapid diagnostic tests (RDTs) remain the main point-of-care tests for diagnosis of symptomatic <jats:italic>Plasmodium falciparum<\/jats:italic> malaria in endemic areas. However, parasites with gene deletions in the most common RDT target, histidine rich protein 2 (<jats:italic>pfhrp2<\/jats:italic>\/HRP2), can produce false-negative RDT results leading to inadequate case management. The objective of this study was to determine the prevalence of <jats:italic>hrp2\/3<\/jats:italic> deletions causing false-negative RDT results in Vietnam (Gia Lai and Dak Lak provinces).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Individuals presenting with malaria symptoms at health facilities were screened for <jats:italic>P. falciparum<\/jats:italic> infection using light microscopy and HRP2-RDT (SD Bioline Malaria Antigen Pf\/Pv RDT, Abbott). Microscopically confirmed <jats:italic>P. falciparum<\/jats:italic> infections were analysed for parasite species by 18S rRNA qPCR, and <jats:italic>pfhrp2<\/jats:italic> and <jats:italic>pfhrp3<\/jats:italic> exon2 deletions were investigated by nested PCR. <jats:italic>pfhrp2<\/jats:italic> amplicons were sequenced by the Sanger method and HRP2 plasma levels were determined by enzyme-linked immunosorbent assay (ELISA).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The prevalence of false-negative RDT results among symptomatic cases was 5.6% (15\/270). No <jats:italic>pfhrp2<\/jats:italic> and <jats:italic>pfhrp3<\/jats:italic> deletions were identified. False-negative RDT results were associated with lower parasite density (p\u2009=\u20090.005) and lower HRP2 plasma concentrations (p\u2009&lt;\u20090.001), as compared to positive RDT.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The absence of <jats:italic>hrp2\/3<\/jats:italic> deletions detected in this survey suggests that HRP2-based malaria RDTs remain effective for the diagnosis of symptomatic <jats:italic>P. falciparum<\/jats:italic> malaria in Central Vietnam.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12936-022-04399-w","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T17:02:49Z","timestamp":1670259769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Surveillance of pfhrp2 and pfhrp3 gene deletions among symptomatic Plasmodium falciparum malaria patients in Central Vietnam"],"prefix":"10.1186","volume":"21","author":[{"given":"Ngo Duc","family":"Thang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Rovira-Vallbona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Thi Huong","family":"Binh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dang Viet","family":"Dung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Thi Hong","family":"Ngoc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tran Khanh","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tran Thanh","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly A.","family":"Edgel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,5]]},"reference":[{"key":"4399_CR1","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1083\/jcb.103.4.1269","volume":"103","author":"RJ Howard","year":"1986","unstructured":"Howard RJ, Uni S, Aikawa M, Aley SB, Leech JH, Lew AM, et al. Secretion of a malarial histidine-rich protein (Pf HRP II) from Plasmodium falciparum-infected erythrocytes. J Cell Biol. 1986;103:1269\u201377.","journal-title":"J Cell Biol"},{"key":"4399_CR2","unstructured":"UNITAID-World Health Organization. Malaria diagnostics landscape update. Geneva: World Health Organization; 2015. http:\/\/unitaid.org\/assets\/Malaria_Diagnostics_Landscape_Update_Fe_2015.pdf."},{"key":"4399_CR3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/1475-2875-9-129","volume":"9","author":"J Baker","year":"2010","unstructured":"Baker J, Ho MF, Pelecanos A, Gatton M, Chen N, Abdullah S, et al. Global sequence variation in the histidine-rich proteins 2 and 3 of Plasmodium falciparum: implications for the performance of malaria rapid diagnostic tests. Malar J. 2010;9:129.","journal-title":"Malar J"},{"key":"4399_CR4","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1186\/s12936-020-03460-w","volume":"19","author":"ML Gatton","year":"2020","unstructured":"Gatton ML, Chaudhry A, Glenn J, Wilson S, Ah Y, Kong A, et al. Impact of Plasmodium falciparum gene deletions on malaria rapid diagnostic test performance. Malar J. 2020;19:392.","journal-title":"Malar J"},{"key":"4399_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008091","volume":"5","author":"D Gamboa","year":"2010","unstructured":"Gamboa D, Ho M-F, Bendezu J, Torres K, Chiodini PL, Barnwell JW, et al. A large proportion of P. falciparum isolates in the Amazon Region of Peru Lack pfhrp2 and pfhrp3: implications for malaria rapid diagnostic tests. PLoS ONE. 2010;5: e8091.","journal-title":"PLoS ONE"},{"key":"4399_CR6","doi-asserted-by":"publisher","first-page":"558","DOI":"10.2471\/BLT.20.250621","volume":"98","author":"R Thomson","year":"2020","unstructured":"Thomson R, Parr JB, Cheng Q, Chenet S, Perkins M, Cunningham J. Prevalence of Plasmodium falciparum lacking histidine-rich proteins 2 and 3: a systematic review. Bull World Health Organ. 2020;98:558\u2013658.","journal-title":"Bull World Health Organ"},{"key":"4399_CR7","doi-asserted-by":"publisher","first-page":"462","DOI":"10.3201\/eid2403.171723","volume":"24","author":"A Berhane","year":"2018","unstructured":"Berhane A, Anderson K, Mihreteab S, Gresty K, Rogier E, Mohamed S, et al. Major threat to malaria control programs by Plasmodium falciparum lacking histidine-rich protein 2, Eritrea. Emerg Infect Dis. 2018;24:462\u201370.","journal-title":"Emerg Infect Dis"},{"key":"4399_CR8","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1080\/22221751.2020.1815590","volume":"9","author":"X Iriart","year":"2020","unstructured":"Iriart X, Menard S, Chauvin P, Mohamed HS, Charpentier E, Mohamed MA, et al. Misdiagnosis of imported falciparum malaria from African areas due to an increased prevalence of pfhrp2\/pfhrp3 gene deletion: the Djibouti case. Emerg Microbes Infect. 2020;9:1984\u20137.","journal-title":"Emerg Microbes Infect"},{"key":"4399_CR9","unstructured":"WHO. Protocol for estimating the prevalence of pfhrp2\/pfhrp3 gene deletions among symptomatic falciparum patients with false-negative RDT results. Geneva: World Health Organization; 2018. https:\/\/www.who.int\/docs\/default-source\/malaria\/mpac-documentation\/mpac-oct2017-hrp2-deletion-protocol-session4.pdf?sfvrsn=2c9dfaf4_2."},{"key":"4399_CR10","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12936-018-2372-8","volume":"17","author":"SM Goldlust","year":"2018","unstructured":"Goldlust SM, Thuan PD, Giang DDH, Thang ND, Thwaites GE, Farrar J, et al. The decline of malaria in Vietnam, 1991\u20132014. Malar J. 2018;17:226.","journal-title":"Malar J"},{"key":"4399_CR11","unstructured":"Cunningham J. Update on Plasmodium falciparum hrp2\/3 gene deletions. Malaria Policy Advisory Committee Meeting, World Health Organization; 2017. https:\/\/www.who.int\/malaria\/mpac\/mpac-mar2017-hrp2-3-deletions-session7-presentation.pdf."},{"key":"4399_CR12","volume-title":"Management of severe malaria: a practical handbook","author":"WHO","year":"2012","unstructured":"WHO. Management of severe malaria: a practical handbook. 3rd ed. Geneva: World Health Organization; 2012.","edition":"3"},{"key":"4399_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071539","volume":"8","author":"E Kamau","year":"2013","unstructured":"Kamau E, Alemayehu S, Feghali KC, Saunders D, Ockenhouse CF. Multiplex qPCR for detection and absolute quantification of malaria. PLoS ONE. 2013;8: e71539.","journal-title":"PLoS ONE"},{"key":"4399_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076316","volume":"8","author":"R Wampfler","year":"2013","unstructured":"Wampfler R, Mwingira F, Javati S, Robinson L, Betuela I, Siba P, et al. Strategies for detection of Plasmodium species gametocytes. PLoS ONE. 2013;8: e76316.","journal-title":"PLoS ONE"},{"key":"4399_CR15","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1086\/432010","volume":"192","author":"J Baker","year":"2005","unstructured":"Baker J, McCarthy J, Gatton M, Kyle DE, Belizario V, Luchavez J, et al. Genetic diversity of Plasmodium falciparum histidine-rich protein 2 (PfHRP2) and its effect on the performance of PfHRP2-based rapid diagnostic tests. J Infect Dis. 2005;192:870\u20137.","journal-title":"J Infect Dis"},{"key":"4399_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12936-018-2287-4","volume":"17","author":"JB Parr","year":"2018","unstructured":"Parr JB, Anderson O, Juliano JJ, Meshnick SR. Streamlined, PCR-based testing for pfhrp2- and pfhrp3-negative Plasmodium falciparum. Malar J. 2018;17:137.","journal-title":"Malar J"},{"key":"4399_CR17","first-page":"103","volume":"72","author":"G Snounou","year":"2002","unstructured":"Snounou G. Genotyping of Plasmodium spp. nested PCR. Methods Mol Med. 2002;72:103\u201316.","journal-title":"Methods Mol Med"},{"key":"4399_CR18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/1475-2875-7-195","volume":"7","author":"PH Corran","year":"2008","unstructured":"Corran PH, Cook J, Lynch C, Leendertse H, Manjurano A, Griffin J, et al. Dried blood spots as a source of anti-malarial antibodies for epidemiological studies. Malar J. 2008;7:195.","journal-title":"Malar J"},{"key":"4399_CR19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12936-022-04060-6","volume":"21","author":"NN San","year":"2022","unstructured":"San NN, Kien NX, Manh ND, Van Thanh N, Chavchich M, Binh NTH, et al. Cross-sectional study of asymptomatic malaria and seroepidemiological surveillance of seven districts in Gia Lai province, Vietnam. Malar J. 2022;21:40.","journal-title":"Malar J"},{"key":"4399_CR20","doi-asserted-by":"publisher","first-page":"21082","DOI":"10.1038\/s41598-021-00714-8","volume":"11","author":"S Mihreteab","year":"2021","unstructured":"Mihreteab S, Anderson K, Pasay C, Smith D, Gatton ML, Cunningham J, et al. Epidemiology of mutant Plasmodium falciparum parasites lacking histidine-rich protein 2\/3 genes in Eritrea 2 years after switching from HRP2-based RDTs. Sci Rep. 2021;11:21082.","journal-title":"Sci Rep"},{"key":"4399_CR21","unstructured":"WHO. Methods manual for laboratory quality control testing of malaria RDTs. Geneva: World Health Organization; 2020. https:\/\/www.who.int\/publications\/m\/item\/methods-manual-for-laboratory-quality-control-testing-of-malaria-rdts."},{"key":"4399_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157949","volume":"11","author":"PK Bharti","year":"2016","unstructured":"Bharti PK, Chandel HS, Ahmad A, Krishna S, Udhayakumar V, Singh N. Prevalence of pfhrp2 and\/or pfhrp3 gene deletion in Plasmodium falciparum population in eight highly endemic States in India. PLoS ONE. 2016;11: e0157949.","journal-title":"PLoS ONE"},{"key":"4399_CR23","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1186\/s12936-017-2061-z","volume":"16","author":"H Gupta","year":"2017","unstructured":"Gupta H, Matambisso G, Galatas B, Cister\u00f3 P, Nhamussua L, Simone W, et al. Molecular surveillance of pfhrp2 and pfhrp3 deletions in Plasmodium falciparum isolates from Mozambique. Malar J. 2017;16:416.","journal-title":"Malar J"},{"key":"4399_CR24","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.actatropica.2012.09.015","volume":"125","author":"N Kumar","year":"2013","unstructured":"Kumar N, Pande V, Bhatt RM, Shah NK, Mishra N, Srivastava B, et al. Genetic deletion of HRP2 and HRP3 in Indian Plasmodium falciparum population and false negative malaria rapid diagnostic test. Acta Trop. 2013;125:119\u201321.","journal-title":"Acta Trop"},{"key":"4399_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094193","volume":"9","author":"ER Alves","year":"2014","unstructured":"Alves ER, Gomes LT, Ribatski-Silva D, Mendes CRJ, Leal-Santos FA, Sim\u00f5es LR, et al. Assumed white blood cell count of 8,000 cells\/\u03bcL overestimates malaria parasite density in the Brazilian Amazon. PLoS ONE. 2014;9: e94193.","journal-title":"PLoS ONE"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-022-04399-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-022-04399-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-022-04399-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T17:12:34Z","timestamp":1670260354000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-022-04399-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,5]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["4399"],"URL":"https:\/\/doi.org\/10.1186\/s12936-022-04399-w","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,5]]},"assertion":[{"value":"25 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was obtained from the Vietnam National Institute of Malaria, Parasitology and Entomology Institutional Review Board (Ministry of Health, Vietnam). Extra-mural review was conducted in accordance with U.S. Department of the Navy Human Research Protection Program guidelines in compliance with all applicable federal regulations governing the protection of human subjects. Written informed consent was obtained from participants and parents or guardians of minor participants, prior to enrolment. Children aged 10 to 17\u00a0years of age provided assent to participate in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate."}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"371"}}